
Cooper Companies (COO) Stock Forecast & Price Target
Cooper Companies (COO) Analyst Ratings
Bulls say
Cooper Companies is projected to have sustainable growth and increasing earnings, driven mainly by CooperSurgical's strong sales in the F1Q26 quarter and success in the fertility market. This, along with management's plans for reducing debt and a favorable pricing environment in the U.S. for contact lens companies, makes for a positive long-term outlook. However, risks such as competition in the contact lens market and currency headwinds should be monitored.
Bears say
Cooper Companies is facing headwinds in the APAC region, especially in China and Japan, for its contact lens business. These challenges have resulted in lower growth for CVI in the last three quarters and may continue to affect growth in the future. Additionally, the pricing dynamics in the U.S. market and a difficult APAC comparison in the second half of the year could also impact growth. Despite the potential for a stronger second half, there may be more risk than upside opportunity for the current growth forecast of ~4%, leading to concerns about the achievability of the company's ~100 bp organic growth guidance for the full year. With MyDay MiSight, the company has implemented a pricing strategy that sets the cost at parity with its legacy product, potentially limiting upside to the +20-25% growth target for myopia management revenue in FY'26. This, along with a potential need for a reset of guidance due to lower growth expectations, may affect the company's financials, with a decrease in revenue and EPS projected for FY'26 and FY'27.
This aggregate rating is based on analysts' research of Cooper Companies and is not a guaranteed prediction by Public.com or investment advice.
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares